Results 21 to 30 of about 8,034,026 (305)
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study [PDF]
, 2019 Graft-versus-host disease is the main cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. First-line treatment is based on the use of high doses of corticosteroids.González Vicent, Marta, Miguel A. Díaz Pérez, Ferra-Coll, Christelle, Molina Angulo, Blanca, Pedro A. González Sierra, Cristina Calderón Cabrera, Ildefonso Espigado Tocino, Valcárcel, David, Pérez, Estefanía, Viguria-Alegria, Maria C, Parody-Porras, Rocio, Blanca Molina Angulo, David Valcárcel Ferreiras, Diaz-Perez, Miguel A, Parra Salinas, Ingrid M., Caballero-Barrigon, Dolores, María C. Viguria Alegría, Lopez-Corral, Lucia, João Mende, María, Irene García Cadenas, Calderón Cabrera, C, Poch, Marc, Silvanna Saavedra Gerosa, Valcárcel Ferreiras, David, Ortí, Guillermo, López Corral, Lucía, Valentín García-Gutiérrez, Montoro Gómez, Juan, Francisco J. Márquez Malaver, Parra-Salinas, Ingrid M, Calderon-Cabrera, Cristina, Grupo Español de Trasplante Hematopoyético (GETH), Parra Salinas, Ingrid M, De la Cámara LLanzá, Rafael, Caballero-Velazquez, Teresa, Gonzalez-Vicent, Marta, González Sierra, Pedro A., Parody Porras, Rocío, Viguria Alegría, María C., Montoro-Gomez, Juan, Pérez-Simón, José A., De-la-Camara-LLanza, Rafael, Martino-Bofarull, Rodrigo, María T. Zudaire Ripa, Garcia-Cadenas, Irene, Molina-Angulo, Blanca, Rodriguez-Torres, Nancy, Viguria Alegría, María C, Marc Poch, Rodrigo Martino Bofarull, Ariadna Pérez Martínez, Martino Bofarull, Rodrigo, Sánchez Ortega, Isabel, Velázquez-Kennedy, Kyra, Saavedra Gerosa, Silvanna, Márquez Malaver, Francisco J, Espigado Tocino, Ildefonso, Valcarcel-Ferreiras, David, García-Gutiérrez, Valentín, Jorge Sierra, Escamilla Gómez, Virginia, Sanz Caballer, Jaime, Díaz Pérez, Miguel A., Espigado-Tocino, Ildefonso, Caballero Barrigón, Dolores, Sierra, Jorge, Rodríguez Torres, Nancy, Christelle Ferra Coll, María João Mende, Perez-Simon, Jose A, Kyra Velázquez-Kennedy, Ferra Coll, Christelle, Marta González Vicent, Garcia Cadenas, Irene, Juan Montoro Gómez, Teresa Caballero-Velázquez, Nancy Rodríguez Torres, Isabel Sánchez Ortega, Márquez Malaver, Francisco J., Caballero Velazquez, Teresa, Molés, Paula, Marquez-Malaver, Francisco J, Zudaire Ripa, María T, Lucía López Corral, Ingrid M. Parra Salinas, González Sierra, Pedro A, Sanz-Caballer, Jaime, de la Camara, Rafael, José A Pérez-Simón, Calderón Cabrera, Cristina, Gonzalez-Sierra, Pedro A, Sanchez-Ortega, Isabel, Rafael De la Cámara LLanzá, Díaz Pérez, Miguel A, Escamilla-Gomez, Virginia, Zudaire-Ripa, Maria T, Ferrá, Christelle, Saavedra-Gerosa, Silvanna, Jaime Sanz Caballer, Estefanía Pérez, Perez-Martinez, Ariadna, Zudaire Ripa, María T., Rocío Parody Porras, Guillermo Orti, Paula Molés, Dolores Caballero Barrigón, Pérez Martínez, Ariadna, Universitat Autònoma de Barcelona, João-Mende, Maria, Virginia Escamilla Gómez +109 morecore +3 more sourcesProlonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Haematologica, 2015 Effective pharmacological strategies employed in allogeneic hematopoietic cell transplantation should prevent serious chronic graft-versus-host disease and facilitate donor-recipient immune tolerance.Joseph Pidala, Jongphil Kim, Melissa Alsina, Ernesto Ayala, Brian C. Betts, Hugo F. Fernandez, Teresa Field, Heather Jim, Mohamed A. Kharfan-Dabaja, Frederick L. Locke, Asmita Mishra, Taiga Nishihori, Leonel Ochoa-Bayona, Lia Perez, Marcie Riches, Claudio Anasetti +15 moredoaj +1 more sourceDonor characteristics and hematopoietic stem cell transplantation outcome: experience of a single center in Southern Brazil
Hematology, Transfusion and Cell Therapy, 2018 Background: Hematopoietic stem cell transplantation is a curative treatment for many patients with hematological disorders. Donor–recipient genetic disparity, especially involving the human leukocyte antigen system is a critical factor for transplant ...Alessandra Paz, Lisandra Rigoni, Gustavo Fischer, Monise Schittler, Annelise Pezzi, Vanessa Valim, Alice Dahmer, Bruna Zambonato, Bruna Amorin, Filipe Sehn, Maria Aparecida da Silva, Liane Daudt, Lucia Silla +12 moredoaj +1 more sourceBendamustine Conditioning Skews Murine Host DCs Toward Pre-cDC1s and Reduces GvHD Independently of Batf3
Frontiers in Immunology, 2020 Graft-versus-host disease (GvHD) remains the second leading cause of death in allogeneic hematopoietic stem cell transplantation recipients, highlighting the need for improved preventative strategies.Megan S. Molina, Megan S. Molina, Jessica Stokes, Emely A. Hoffman, Jelena Eremija, Yi Zeng, Yi Zeng, Richard J. Simpson, Richard J. Simpson, Richard J. Simpson, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis, Emmanuel Katsanis +14 moredoaj +1 more sourceTransfusion-associated graft-vs-host disease – A case report [PDF]
, 2016 Transfusion-associated graft-vs-host disease (TAGVHD) is a rare complication of blood transfusion. Unlike GVHD associated with hematopoietic stem cell transplantation TA-GVHD involves the patient's bone marrow and leads to bone marrow aplasia.Bhattacharyya, Jina; Department of Clinical Hematology, Gauhati Medical College, Guwahati, India, Dutta, Sangit; Department of Medicine, Gauhati Medical College, Guwahati, India, Kakati, Bhaskar Jyoti; International Hospital, Guwahati, India, Bhattacharyya, Mrinal; International Hospital, Guwahati, India, Raj, Aishwarya; Department of Clinical Hematology, Gauhati Medical College, Guwahati, India, Khound, Nilom; International Hospital, Guwahati, India +5 morecore +1 more sourceSevere acute graft versus host disease after lung transplant: report of a case successfully treated with high dose corticosteroids
, 2009 Acute graft vs host disease is an uncommon and usually fatal complication of lung transplant for which no effective therapy exists. All 8 patients with grade 3 to 4 acute graft vs host disease after lung transplantation described in literature died ...LAGHI PASINI F., FILIPPI R., LUZZI L., FOSSI A., VOLTOLINI L., MARCHI B., ROTTOLI P., GOTTI G., Luca Luzzi, Franco Laghi Pasini, Antonella Fossi, Voltolini, Luca, Luca Voltolini, Bruna Marchi, Giuseppe Gotti, Rita Filippi, Paola Rottoli +16 morecore +2 more sourcesMesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease [PDF]
, 2010 Background Multipotent mesenchymal stromal cells suppress T-cell function in vitro, a property that has underpinned their use in treating clinical steroid-refractory graft-versus-host disease after allogeneic hematopoietic stem cell transplantation ...K. Atkinson, Turner, Brie E., K. Kollar, L. J. Sinfield, Kollar, Katarina, Cullup, Hanna, Sinfield, Laura J., B. E. Turner, H. Cullup, N. J. Waterhouse, Hart, Derek N. J., Atkinson, Kerry, Rice, Alison M., M. E. Christensen, Christensen, Melinda E., Hart, Derek N.J., A. M. Rice, Waterhouse, Nigel J., D. N. J. Hart, Cullup, Hannah +19 morecore +1 more sourceConsensus on graft-versus-host disease
Journal of Bone Marrow Transplantation and Cellular TherapyGraft-versus-host disease (GvHD) remains the mainly cause of late non-relapse mortality following allogeneic hematopoietic cell transplantation. Advancements in novel immunosuppressive therapies and prophylactic regimens necessitate an update to current ...Vaneuza Araújo Moreira Funke, João Victor Piccolo Feliciano, Giancarlo Fatobene, Maria Cláudia Rodrigues Moreira, Antonio Vaz de Macedo, Rita de Cássia Barbosa da Silva Tavares, Marcia de Matos Silva, Marcos Paulo Colella, Morgani Rodrigues, Luis Fernando da Silva Bouzas, Afonso Celso Vigorito +10 moredoaj +1 more source
